Pfizer names new UK managing director

US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president, formally taking over from Susan Rienow who was appointed Pfizer’s global chief marketing officer in July.

Mr McGinley joined Pfizer in 2011 and has been leading the UK Primary Care division since November 2023, a role which has most recently involved supporting DHSC, UKHSA and the National Health Service (NHS) with the implementation of a national immunization program. He has acted as interim UK country president for the past two months and he has been a member of the trade group Association of the British Pharmaceutical Industry (ABPI) board since February 2024.

Commenting on his appointment, Mr McGinley said: “It is a privilege to take on this responsibility, knowing that every year millions of people rely on Pfizer medicines and vaccines across the UK. While our country undoubtedly faces persistent and growing healthcare challenges, I believe that Pfizer has the science, scale and experience to support in tackling these and easing the associated economic and societal pressures. We have shown that we can move with urgency to deliver scientific breakthroughs and we remain committed to working with our partners across the life sciences to better manage disease, free up healthcare services and help people live healthier and more prosperous lives.”